2016 FDA Approval Pharmacokinetics Small Molecule 
Metabolite Tales Blog
JANUARY 23, 2024
Metabolism of 2023 FDA Approved Small Molecules – PART 1 By Julia Shanu-Wilson 2023 was a fruitful year for drug approvals by the FDA, with a crop of 34 small molecules out of a total of 55 new drugs [1]. References [1] 2023 Novel Small Molecule FDA Drug Approvals.
The Pharma Data
DECEMBER 15, 2020
Under the terms of the amended agreement , originally executed in 2016 with Bristol Myers’ Celgene, an undisclosed fee was paid to Anokion to include KAN-101 for the treatment of celiac disease in the exclusive global collaboration. Small Molecule Inhibitors. The secondary outcome involves pharmacokinetic endpoints.
Expert insights. Personalized for you.
52 
Let's personalize your content